Evidence map›Paper›PMID 38476381›Full record

ArticleFrontiers in cardiovascular medicine2024

Correlation of the serum cell division cycle 42 with CD4

Hui Peng, Xugang Wang, Longfei Zhang, Yang Su, Jieli Yan, Xin Wu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hui PengDepartment of Cardiac Surgery, Xingtai People's Hospital, Xingtai, Hebei, China.
Xugang WangDepartment of Cardiovascular Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Longfei ZhangDepartment of Cardiac Surgery, Xingtai People's Hospital, Xingtai, Hebei, China.
Yang SuDepartment of Cerebrovascular Neurosurgery, Xingtai People's Hospital, Xingtai, Hebei, China.
Jieli YanDepartment of Cardiac Surgery, Xingtai People's Hospital, Xingtai, Hebei, China.
Xin WuDepartment of Cardiac Surgery, Xingtai People's Hospital, Xingtai, Hebei, China.
Xingtai People's Hospital · CNHebei Medical University · CNFirst Affiliated Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Cell division cycle 42 (CDC42) regulates CD4 Methods: Serum CDC42 and peripheral blood T-helper (Th) 1, Th2, and Th17 cells were detected in 127 TBAD patients by enzyme-linked immunosorbent assay and flow cytometry, respectively. Serum CDC42 was also quantified in 30 healthy controls. Results: Serum CDC42 was decreased in TBAD patients vs. healthy controls (median [interquartile range (IQR)]: 418.0 (228.0-761.0) pg/ml vs. 992.0 (716.3-1,445.8) pg/ml, Conclusion: Serum CDC42 negatively associates with Th17 cells and is independently correlated with decreased in-hospital mortality risk in TBAD patients.

Indexed as

CD4+T cell subsetscell division cycle 42in-hospital mortalityprognostic valueStanford type B aortic dissection

Identifiers

PMID38476381
PMCPMC10927740
OpenAlexW4392196332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.